|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
FY2022
12 months to Apr 30, 2022
|
|
|---|---|---|---|---|---|
| OPERATING EXPENSES | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| OTHER EXPENSE, NET | |||||
| Interest income | |||||
| Interest expense | |||||
| Total other expense, net | |||||
| NET LOSS | |||||
| Dividends on preferred shares | |||||
| Deemed dividend on warrant modification issued with preferred | |||||
| Deemed dividend on warrant modification issued with preferred shares | |||||
| NET LOSS AVAILABLE TO COMMON SHARES | |||||
| Basic net loss per common share | |||||
| Diluted net loss per common share | |||||
| Basic weighted average common shares outstanding | |||||
| Diluted weighted average common shares outstanding | |||||
Loading...